Form D · Other Health Care
Ascus Biosciences, Inc.
San Diego, CA · CIK 0001672679
Offering snapshot reported Jun 13, 2019 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 31, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 13, 2019 | Initial | $5,000,000 | No comparison | 10 | SEC filing |
| Sep 5, 2018 | Initial | $6,000,000 | No comparison | 6 | SEC filing |
| Jul 11, 2017 | Initial | $5,000,000 | No comparison | 9 | SEC filing |
| Apr 26, 2016 | Initial | $12,694,128 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-341832
Consists of Convertible Promissory Notes convertible into shares of Preferred Stock of the Issuer.
Source: Form D, filed Jun 13, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mallory Embree | Director, Executive |
| Peter Innes | Director |
| Jim Kim | Director |
| Michael Seely | Director, Executive |
| Thad Simons | Director |
| Erik Torgerson | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
6450 Lusk Blvd Suites E109/209
San Diego, CA, 92121
San Diego, CA, 92121